University of Louisville
Playback speed
10 seconds
CAR T-Cell Therapy has Redefined the Treatment Algorithm for Relapsed and/or Refractory Diffuse Large B-cell Lymphoma
By
University of Louisville
FEATURING
Mohamed A Kharfan-Dabaja
By
University of Louisville
FEATURING
Mohamed A Kharfan-Dabaja
127 views
March 16, 2023
Mohamed A. Kharfan-Dabaja, M.D., MBA, FACP, Professor of Medicine; Vice Chair, Hematology; Director, Blood and ...
read more ↘ Marrow Transplantation and Cellular Therapies; and Medical Director, Cancer Research Office (Florida Campus) at the Mayo Clinic College of Medicine and Science, focused on discussing the current indications for CAR T-cell therapy in patients with diffuse large B-cell lymphoma, identifying the unique toxicities associated with CAR T-cell therapy, and describing the prognosis associated with CAR T-cell therapy failure and available options.
↖ read less
read more ↘ Marrow Transplantation and Cellular Therapies; and Medical Director, Cancer Research Office (Florida Campus) at the Mayo Clinic College of Medicine and Science, focused on discussing the current indications for CAR T-cell therapy in patients with diffuse large B-cell lymphoma, identifying the unique toxicities associated with CAR T-cell therapy, and describing the prognosis associated with CAR T-cell therapy failure and available options.
↖ read less
Comments 0
Login to view comments.
Click here to Login